Clinical impact of cardiac magnetic resonance in patients with suspected coronary artery disease associated with chronic kidney disease (AQUAMARINE-CKD study): study protocol for a randomized controlled trial

Teruo Noguchi,Hideki Ota,Naoya Matsumoto,Yoshiaki Morita,Akira Oshita,Eiji Kawasaki,Tomohiro Kawasaki,Kensuke Moriwaki,Shingo Kato,Kazuki Fukui,Tomoya Hoshi,Hiroaki Watabe,Tomoaki Kanaya,Yasuhide Asaumi,Yu Kataoka,Fumiyuki Otsuka,Kensuke Takagi,Shuichi Yoneda,Kenichiro Sawada,Takamasa Iwai,Hideo Matama,Satoshi Honda,Masashi Fujino,Hiroyuki Miura,Kunihiro Nishimura,Kei Takase
DOI: https://doi.org/10.1186/s13063-022-06820-w
IF: 2.728
2022-10-25
Trials
Abstract:Although screening for coronary artery disease (CAD) using computed tomography coronary angiography in patients with stable chest pain has been reported to be beneficial, patients with chronic kidney disease (CKD) might have limited benefit due to complications of contrast agent nephropathy and decreased diagnostic accuracy as a result of coronary artery calcifications. Cardiac magnetic resonance (CMR) has emerged as a novel imaging modality for detecting coronary stenosis and high-risk coronary plaques without contrast media that is not affected by coronary artery calcification. However, the clinical use of this technology has not been robustly evaluated.
medicine, research & experimental
What problem does this paper attempt to address?